Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Summary

This study will evaluate the efficacy and safety of CTP-656 in patients with cystic fibrosis (CF) who have a cystic fibrosis transmembrane conductance regulator (CFTR) gating mutation.

Timeline

Start

2016-12

Primary completion

2017-08

Completion

2017-08

Outcome

Outcome not reported

Stopped: “Decision by Sponsor.”

Drugs

Indications